3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
12
Non-Muscle Invasive Bladder Neoplasms
4
Carcinoma, Transitional Cell
2
Ureteral Neoplasms
1
Prostatic Neoplasms
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Kidney Neoplasms
1
Hematuria
1
Carcinoma in Situ
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Cystoscopy
×
1 year
×
Clear all
NCT07037589
2025-11-21
BLUSH
Vastra Gotaland Region
Recruiting
300 enrolled